The Bundibugyo Ebola virus — The Bundibugyo virus
This outbreak is caused by the Bundibugyo species of Ebola virus.
The Bundibugyo species
Identified in 2007, it had caused only two outbreaks before this one.
- Identified in
- 2007in Uganda, in the Bundibugyo district, which gave it its name
- Known outbreaks
- 3Uganda 2007, Isiro (DRC) 2012, and this one
- Fatality rate
- 25 to 50%in past outbreaks; 48.9% of confirmed cases in this one
- Licensed vaccine
- noneErvebo used in research since August 2026; TUMAINI-TRIAL since 23 October
- Licensed treatment
- nonesupportive care; several candidates in clinical trials
One species among four
- Zaire
- Sudan
- Taï Forest
- Bundibugyothis outbreak
The Ebola virus comprises six species, four of which cause disease in humans: Zaire, Sudan, Taï Forest and Bundibugyo. This one is named after the Ugandan district where it was identified in 2007. Before 2026, it had caused only two outbreaks: in Uganda in 2007, then in Isiro, in today's Haut-Uélé, in 2012.
What genetics has revealed
Sequencing does more than confirm the species. Comparing genomes with one another traces them back to a common ancestor, dates the real start of transmission and measures how fast the outbreak spread.
Three findings from the analyses published by INRB and its partners
- 1a recent spilloverfrom the animal reservoir
The 2026 virus descends neither from the 2007 outbreak in Uganda nor from the 2012 one in Isiro.
- 2late February 2026the common ancestor of the sequenced genomes
Nearly three months before the official declaration of 15 May: the virus was circulating unseen.
- 321 daysthe doubling time, roughly
Growth accelerated from March to June, then eased.
Seventeen outbreaks in fifty years
39 outbreaks worldwide since 1976
The DRC's 17th Ebola outbreak is already the largest in the country's history: 11,680 confirmed cases as of 18 Nov 2026, 3.4 times as many as the 2018-2020 North Kivu outbreak. It is also, by far, the largest ever caused by the Bundibugyo species. Worldwide, only the West Africa epidemic (2014-2016) was larger.
Since the virus was discovered in 1976, the world has seen 39 Ebola outbreaks, including this one. With 11,680 confirmed cases as of 18 Nov 2026, it is by far the largest ever caused by the Bundibugyo species. Worldwide, only the West Africa epidemic (2014-2016) was larger.
Past outbreaks: confirmed and probable cases (CDC, History of Ebola Disease Outbreaks). Current outbreak, ongoing: confirmed cases only (SitRep no. 188, 18 Nov 2026).
Past outbreaks: confirmed and probable cases (CDC, History of Ebola Disease Outbreaks), excluding Reston virus, laboratory infections and cases exported from West Africa. “Sudan”: present-day South Sudan. Current outbreak, ongoing: confirmed cases in the DRC (SitRep no. 188, 18 Nov 2026).
Day by day
What an infected person goes through, from infection to recovery or death, and what teams on the ground do to treat them and protect those around them.
Infection
Direct contact with the blood, secretions or body of a sick or deceased person — never through the air.
What the response does: safe and dignified burials, protection of health workers.
Incubation
No symptoms, and not contagious. 8 to 10 days on average.
Contact tracing: each contact is seen every day for 21 days, to be isolated at the first sign.
Early phase
Fever, intense fatigue, muscle pain, headache, sore throat — easily mistaken for malaria or typhoid.
Alert and test: diagnosis is confirmed by RT-PCR on a blood sample.
Advanced phase
Vomiting, diarrhoea, rash, kidney and liver damage, sometimes bleeding.
Treatment centre: intensive supportive care — rehydration, oxygen, monitoring.
Recovery or death
The species' historical fatality rate is 25 to 50%. In this outbreak, 48.9% of confirmed cases have died so far.
Recovery declared after two negative tests; 3,190 people recovered as of 18 Nov 2026.
Cases and deaths, by age
Cases and deaths are not distributed the same way. Comparing the two shows which age groups die more often than they fall ill.
Women and men
As of 5 Aug 2026, the latest published breakdown. Based on the 3,454 cases and 1,124 deaths with known age and sex (85.2% of cases, 60.8% of deaths).
Children
UNICEF, as of 4 Nov 2026, among all confirmed cases (report published on 13 Nov 2026). “All ages”: INSP, fatality rate on the same day, deaths outside treatment centres since 13 Jul 2026.
Vaccines and treatments
No vaccine or treatment is yet licensed against Bundibugyo. Those that exist were designed against the Zaire species, hence the trials under way during this outbreak.
On 31 August 2026, WHO clarified the use of Ervebo, the vaccine licensed against the Zaire species, against Bundibugyo virus: efficacy against this species unknown, use restricted to a research setting, with priority for health workers and front-line staff. INSP bulletins report vaccinations of that staff since early September. On 23 October 2026, the TUMAINI-TRIAL clinical trial, devoted to a vaccine against the Bundibugyo strain, was launched in Bunia, at the Ituri provincial laboratory. According to INSP, it pays particular attention to front-line staff, and participation is based on informed consent.
During this outbreak, several candidates are being evaluated in clinical trials against the Bundibugyo species — including the broad-spectrum antibody MBP134, the antiviral remdesivir, and obeldesivir for post-exposure prophylaxis — under WHO coordination. In the absence of a licensed targeted treatment, intensive supportive care (rehydration, oxygenation, monitoring) remains the cornerstone of care and significantly improves the chances of survival.
Go further
- Response →What is done without a vaccine: alerts, testing, contact tracing, treatment centres.
- Frequently asked questions →Transmission, treatments, and what the site's figures mean.
- Timeline →The key dates of the outbreak, from the first alert to today.